Latest news with #BormioliPharma
Reuters
3 days ago
- Business
- Reuters
Gerresheimer cuts guidance for 2025 citing weak demand
June 2 (Reuters) - German packaging and medical equipment maker Gerresheimer ( opens new tab cut its guidance for 2025 on Monday, citing continued weak demand in the cosmetics sector and a decline in demand for containment solutions for liquid medications. It now expects revenues to grow by between 1% and 2% in 2025, down from its previously forecast range of 3-5%, which includes contributions from Bormioli Pharma, it said in a statement. Gerresheimer, which also makes rounded jars for creams and roll-on bottles for deodorants, also lowered its expected adjusted EBITDA margin to 20%, from 22% previously. The company also cut its 2024 dividend to 0.04 euros ($0.0457) per share from the 1.25 euros proposed in February in an effort to maintain financial flexibility, it said. Shares fell as much as 11% after the announcement, and were trading 10.02% down at 1000 GMT, at the bottom of the STOXX 600 (.STOXX), opens new tab index. ($1 = 0.8750 euros)
Reuters
11-04-2025
- Business
- Reuters
Gerresheimer's first-quarter results hit by low demand in moulded glass
April 11 (Reuters) - German packaging and medical equipment maker Gerresheimer ( opens new tab reported a lower organic core profit for the first quarter on Friday, hit by continued lower demand in moulded glass and shift in syringe revenues into later quarters. Its adjusted operating earnings before depreciation and amortisation (EBITDA) were 91.4 million euros ($103.29 million) including recently acquired Bormioli Pharma. They were down 9.3% on an organic basis compared to the same period last year.
